Lipid-lowering drug treatment and mortality among individuals ≥75 years without cardiovascular disease: a population-based cohort study
In this study population of people aged ≥75 years and without CVD at baseline, use of lipid-lowering drugs was associated with significantly lower risks of all-cause and cardiovascular mortality.
Authors
- Zu‐Yao Yang (ORCID: https://orcid.org/0000-0003-2386-2431)
- Ying Huang (ORCID: https://orcid.org/0009-0008-0739-9225)
- Jiayue Zhang (ORCID: https://orcid.org/0000-0001-9219-6335)
- Ying Xiao (ORCID: https://orcid.org/0000-0002-4223-4943)
- Shuting Wang (ORCID: https://orcid.org/0000-0003-1461-3898)
- Weijia Zheng (ORCID: https://orcid.org/0009-0009-2620-7919)
Institutions
- Macau University of Science and Technology (MO)
- Chinese University of Hong Kong (HK)
- Hong Kong Jockey Club (HK)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1093/eurjpc/zwaf515
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Chinese University of Hong Kong